You Are Here: Home » Healthcare » Pharmaceutical PR

2015 FDA Social Media Guidelines to Bring More Clarity?

Recently, the FDA released a list of approximately 100 items of draft guidance it plans to issue or update in 2015. On the list are a few guidelines pertaining to social media, which pleases many of us in PR who have been waiting (somewhat) patiently for direction over the past few years. As we wait, we thought we’d take a moment to address a few of the highlights we can expect this year. Of particular inte ...

Read more

Big Data Takes Big Steps into Healthcare – Part I

There is a coming explosion in healthcare big data. Why? The big data analytics market swelled to $18.6 billion in 2013 - a whopping 58 percent growth from the previous year.[i] And this data behemoth isn’t standing still. Its economic foot print will grow to $50 billion by 2017.[ii] Dollar signs that big means there is an unfathomable amount of data to be analyzed. And tons of it is being generated by the ...

Read more

Now is the Time for Pharma to Get on Board the Social Media Bandwagon

In today’s digital world, social media has become an important part of an integrated communications strategy. When utilized to its full potential, this powerful communications channel fosters meaningful two-way discussion between a company and its stakeholders. Most industries have climbed on board the social media bandwagon, however the pharmaceutical industry has been slower to make the investment in this ...

Read more

8 Tips for Producing Compelling Patient Videos

In today’s digital world, video has become a powerful way to share and consume information. According to a Forrester report, “Optimizing video content is by far the easiest way to get a first-page organic ranking on Google. Having a video on your homepage can increase your ranking by 50x.” A broad spectrum of Schwartz MSL’s clients are working with our digital production team to crea ...

Read more

Cerulean Pharma and Six Other Boston Area Firms Named to FierceBiotech’s Fierce 15

Today FierceBiotech came out with its annual Fierce 15 list of innovative life sciences companies. We're pleased to congratulate Schwartz client Cerulean Pharma, a leader in designing and developing tumor-targeted nanopharmaceuticals, on their inclusion on the list.John Carroll, the publication's editor-in-chief, notes: "Making it today means actually meeting that unmet medical need, moving the dial on ...

Read more

Tricks of the Social Media Trade for Healthcare Marketers

Working with medical device, medical tech and pharma companies, social media is top of mind. Healthcare marketers grapple with timing, resources, and understanding the appropriate/effective mix of social media tactics in a communications program. We counsel our clients all the time and field the questions: How much should we/can we engage? What should we post? Are we doing enough? What are your other client ...

Read more

Schwartz Ranks in Top Ten for Independent PR Firms!

Spring has sprung and with it, so has O’Dwyer’s annual ranking of independent public relations firms across the industry. Once again, Schwartz Communications was named among the top 10 independent PR firms out of 152 firms nationwide.  Additionally, Schwartz is ranked sixth among the top firms specializing in technology and healthcare respectively. Schwartz is proud to be ranked and recogni ...

Read more

The Power of Sharing in Healthcare

A core component of effective communication strategies for healthcare companies almost always involves identifying and promoting patient success stories. Drug, device, diagnostic or treatment, there is always greater success creating awareness when courageous patients step forward, willing to share their stories of triumph of how innovative medical technology helped them identify or conquer their medical ch ...

Read more

Eli Lilly Takes Up Blogging

Pharma, biotech and medical device companies aren't terribly cowboy when it comes to corporate communications. I'd describe the general mindset as not so much "why wouldn't I share this information?" as "how does disclosing this information help me?"It's not that they don't want to market their companies, their therapies and their expertise, because they do. But on a day-to-day basis, th ...

Read more

Video Moves Beyond Consumer Healthcare PR to Technology, Life Sciences Communications

The Schwartz Digital team has been busy as of late creating videos and podcasts for our healthcare clients. It's great that these services have been so well received--I personally think it's indicative of widespread understanding among the types of companies Schwartz represents that there's way more to telling a story than issuing a press release and getting covered in BioWorld or Medical Device Daily. (Not ...

Read more

Healthcare PR: BioImagene’s Build to USCAP

Say what you will about the effectiveness of conferences in the marketing mix--there are still a lot of shows that companies feel they have to attend in order to see and be seen. In the case of Schwartz client BioImagene, that conference is the annual meeting of the U.S. & Canadian Academy of Pathology (USCAP).BioImagene is one of the companies that dominate USCAP and their PR team is working overtime t ...

Read more